Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Observatory
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Signals Session
  • Bespoke Projects
  • Build Sessions
  • Use Cases
  • Readinessfree
  • Signals
  • Free scan↗free
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
solutions
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Partners
  • Coding for Non-Coders
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
ResearchServicesSignalsAbout
ResearchServicesSignalsAbout
  1. Home
  2. Research
  3. Helix
  4. Multi-Omic Foundation Models for Aging Clocks

Multi-Omic Foundation Models for Aging Clocks

Large models integrating methylome, proteome, and metabolome to estimate biological age.
Back to HelixView interactive version

Multi-omic foundation models for aging clocks are large AI models trained on longitudinal data across multiple biological modalities including DNA methylation (methylome), protein levels (proteome), metabolite levels (metabolome), and clinical data to infer tissue-specific biological age and predict future health trajectories. These comprehensive clocks move beyond single-modality epigenetic clocks (which only use DNA methylation) by integrating multiple types of biological data, enabling more sensitive and accurate measurement of biological aging and the effects of anti-aging interventions, as well as better population stratification in longevity clinical trials where understanding individual aging rates is important.

This innovation addresses the limitation of single-modality aging clocks, where using only one type of data (like DNA methylation) may not capture the full picture of biological aging. By integrating multiple data types, these models can provide more accurate and comprehensive assessments of biological age. Companies and research institutions are developing these advanced aging clocks.

The technology is particularly valuable for longevity research and anti-aging interventions, where accurate measurement of biological age is essential for assessing effectiveness. As the technology improves, it could become a standard tool for aging research and personalized health. However, ensuring accuracy, integrating diverse data types, and understanding what multi-omic biological age means clinically remain challenges. The technology represents an important evolution in aging measurement, but requires continued development to achieve the accuracy and clinical utility needed for widespread use. Success could enable better assessment of aging interventions and personalized health optimization, but the field is still developing and requires more research to understand optimal applications and clinical significance.

TRL
7/9Operational
Impact
5/5
Investment
4/5
Category
Software

Related Organizations

Deep Longevity logo
Deep Longevity

HK · Company

98%

Develops deep learning biomarkers of aging (aging clocks).

Developer
Altos Labs logo
Altos Labs

United States · Research Lab

95%

Biotechnology company focused on cellular rejuvenation programming.

Researcher
Clock.bio logo
Clock.bio

UK · Startup

92%

Decoding the rejuvenation program of human pluripotent stem cells.

Developer
Buck Institute for Research on Aging logo
Buck Institute for Research on Aging

United States · Research Lab

90%

The world's first biomedical research institution exclusively dedicated to research on aging and age-related disease.

Researcher
TruDiagnostic logo
TruDiagnostic

United States · Company

90%

Epigenetic testing company focused on aging algorithms.

Developer
BioAge Labs logo
BioAge Labs

United States · Company

88%

Clinical-stage biotechnology company mapping molecular pathways of aging to develop therapies for immune aging.

Developer
Insilico Medicine logo
Insilico Medicine

HK · Company

85%

A clinical-stage biotechnology company using generative AI for end-to-end drug discovery and research.

Developer
Shift Bioscience logo
Shift Bioscience

United Kingdom · Startup

85%

Uses AI to identify safe rejuvenation genes that can reset the epigenetic clock without causing cancer.

Developer
Retro Biosciences logo
Retro Biosciences

United States · Startup

80%

A startup with a mission to increase healthy human lifespan by ten years, focusing on cellular reprogramming, autophagy, and plasma-inspired therapeutics.

Deployer
Elysium Health logo
Elysium Health

United States · Company

75%

Consumer health company focused on aging research and supplements.

Deployer

Supporting Evidence

Evidence data is not available for this technology yet.

Research this in Signals

Scan Multi-Omic Foundation Models for Aging Clocks for yourself.

Signals turns a topic into a sourced research record you can inspect and rerun. Your first scan is free, and this one starts with Multi-Omic Foundation Models for Aging Clocks already loaded, so edit it or scan as is.